Hoth Therapeutics Inc.

NASDAQ: HOTH · Real-Time Price · USD
1.28
-0.01 (-0.78%)
At close: Aug 15, 2025, 3:59 PM
1.32
3.12%
After-hours: Aug 15, 2025, 07:39 PM EDT

Hoth Therapeutics Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
n/a n/a n/a n/a n/a n/a 59.54K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost of Revenue
n/a 4.35K n/a n/a n/a n/a 29.77K 6.75K 7.9K 15.12K 66.83K 17.63K 15.59K 13.9K 46.87M 6.3K 18.9K 7.44K
Gross Profit
n/a -4.35K n/a n/a n/a n/a 29.77K -6.75K -7.9K -15.12K -66.83K -17.63K -15.59K -13.9K -46.87M -6.3K -18.9K -7.44K
Operating Income
-2.2M -3.48M -2.38M -2.13M -1.65M -2.05M -1.7M -2.09M -1.71M -2.19M -3.42M -2.68M -2.3M -2.66M -3.38M -3.25M -3.2M -4.27M
Interest Income
n/a n/a n/a n/a n/a n/a 751.34 50.99K 1.55 28.11 6.37K n/a n/a n/a n/a n/a n/a n/a
Pretax Income
-2.2M -3.48M -2.38M -2.13M -1.63M -2.04M -1.7M -2.09M -1.87M -2.18M -3.48M -2.64M -2.68M -2.57M -3.48M -3.3M -3.28M -4.26M
Net Income
-2.2M -3.48M -2.38M -2.13M -1.63M -2.04M -1.7M -2.09M -1.87M -2.17M -3.82M -2.6M -2.68M -2.48M -3.48M -3.3M -3.28M -4.26M
Selling & General & Admin
1.16M 1.52M 1.06M 1.23M 1.08M 1.59M 783.22K 1.12M 1.06M 1.25M 1.96M 1.22M 1.29M 1.46M 1.42M 1.09M 1.2M 2.46M
Research & Development
1.04M 1.96M 1.32M 897.51K 566.34K 465.9K 914.6K 974.37K 652.2K 938.88K 1.47M 1.47M 1.01M 989.65K 1.96M 2.16M 1.78M 1.63M
Other Expenses
n/a n/a n/a n/a n/a 105.75K n/a n/a n/a n/a 410.31K -592 -262 212.68K -99.98K n/a -76.86K 7.43K
Operating Expenses
2.2M 3.48M 2.38M 2.13M 1.65M 2.16M 1.7M 2.09M 1.71M 2.19M 3.42M 2.68M 2.3M 2.66M 3.38M 3.25M 3.2M 4.27M
Interest Expense
n/a n/a n/a n/a n/a n/a 9.31K n/a n/a n/a 345.59K n/a n/a n/a 99.98K n/a n/a n/a
Selling & Marketing Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
2.2M 3.48M 2.38M 2.13M 1.65M 2.05M 1.7M 2.09M 1.71M 2.19M 3.42M 2.68M 2.3M 2.66M 3.38M 3.25M 3.2M 4.27M
Income Tax Expense
n/a n/a n/a n/a n/a n/a -1.7K n/a n/a -9.31K 345.59K -40.18K n/a -89.19K n/a -261 -261 -261
Shares Outstanding (Basic)
13.18M 127.28K 7.29M 6.9M 6.88M 4.4M 4.35M 3.48M 3.3M 2.48M 1.2M 1.29M 1.24M 958.99K 893.23K 955.51K 947.78K 707.1K
Shares Outstanding (Diluted)
13.18M 127.28K 7.29M 6.9M 6.88M 4.4M 4.35M 3.48M 3.3M 2.48M 1.2M 1.29M 1.24M 958.99K 893.23K 955.54K 947.78K 707.1K
EPS (Basic)
-0.17 -27.31 -0.33 -0.31 -0.24 -0.46 -0.39 -0.6 -0.57 -0.88 -3.19 -2.02 -2.16 -2.59 -3.9 -3.45 -3.46 -6.03
EPS (Diluted)
-0.17 -27.31 -0.33 -0.31 -0.24 -0.46 -0.39 -0.6 -0.57 -0.88 -3.19 -2.02 -2.16 -2.59 -3.9 -3.45 -3.46 -6.03
EBITDA
-2.2M -3.48M -2.38M -2.13M -1.65M n/a -1.7M -2.09M -1.54M -2.19M -3.23M -2.68M -1.94M -2.66M -3.38M -3.25M -3.2M -4.27M
EBIT
-2.2M -3.48M -2.38M -2.13M -1.65M -2.05M -1.7M -2.09M -1.71M -2.19M -3.42M -2.68M -2.3M -2.66M -3.38M -3.25M -3.2M -4.27M
Depreciation & Amortization
n/a 4.35K n/a n/a n/a 2.05M 1.7M 2.09M 1.71M 2.19M 3.42M 2.68M 2.3M 2.66M 261.00 261.00 261.00 261.00